Manufacturing
WHO supports Member States in strengthening sustainable local production and technology transfer to improve access to safe, effective, quality, and affordable medicines and other health technologies by applying a holistic and strategic approach in collaboration with governments, partners, and other stakeholders. This includes guidance tools, situational analyses for sustainable quality local production, fostering partnerships to seek consensus and a global approach in strengthening local production, capacity building and specialized technical assistance to achieve quality assurance and sustainability, development of skilled human resources, risk-based product selection, and facilitating technology transfer for prioritized products and technologies.
WHO, along with the Medicines Patent Pool and the Act-Accelerator/COVAX, is supporting the technology transfer hub at Afrigen, Cape Town, South Africa, with the aim of building capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub). This site includes information for partners and local producers regarding the range of services available along the entire vaccine value chain.